H1 insights4/27/2023 ![]() H1 graduated from Y Combinator in January 2020 as a bootstrapped company under ten employees, and in less than a year had closed on $70 million in total financing and employed more than 200 people. “H1’s technology already powers a number of critical use cases for large healthcare organizations, and we believe they are uniquely positioned to realize their vision of becoming the central source of truth for actionable data on doctors, research, and treatments.” “We see a critical need for H1’s global healthcare network, especially when it comes to improving diversity in clinical trials and improving healthcare equity,” said Chase Williams, Goldman Sachs. H1 Connect powers H1’s portfolio of solutions including HCP Universe, Trial Landscape, Carevoyance, Precise, and Faculty Opinions. The H1 Connect platform combines data science and technology to synthesize billions of data points, including data on over ten million healthcare providers, 20,000 institutions, 25 million peer-reviewed publications, 420,000 clinical trials, two billion procedures, three billion diagnoses, and over nine million global claims. H1’s mission is to create a healthier future by democratizing access to global expertise, groundbreaking research, discoveries, and connected insights for all – doctors, R&D, industry, and, ultimately, patients. This additional funding allows us to control our own destiny and continue to innovate.” We have improved access to healthcare for millions of patients, and don’t intend to slow down. Our platform has enabled our 200+ clients to gain greater insights and get groundbreaking treatments and therapies to patients around the world efficiently. “Our ability to raise capital at the same terms as our original Series C close is a testament to our significant market opportunity and ability to execute against it. “In a time of volatile markets when many are struggling to secure funding, this extension is a vote of confidence in our ability to advance our mission,” said Ariel Katz, CEO and co-founder of H1. ![]() The funding extends H1’s runway, allowing them to lean into its growth. H1’s valuation holds strong at $773 million to-date. H1, the connecting force for global healthcare professional, clinical, science, and research information, announced today that it raised a Series C extension bringing the total Series C raise to $123 million. Participation from existing investors shows support for and confidence in H1’s trajectory to become the industry’s standard and trusted source of healthcare information
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |